Connecticut 2025 Regular Session

Connecticut House Bill HB07065

Introduced
2/24/25  
Refer
2/24/25  
Report Pass
4/4/25  
Refer
4/11/25  
Report Pass
4/17/25  
Engrossed
5/19/25  

Caption

An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin.

Impact

The implications of HB 07065 on state law include the repeal of certain existing statutes regarding controlled substances and the introduction of fines as penalties for psilocybin possession. This bill could pave the way for more progressive drug policies and may affect law enforcement practices by shifting the focus away from criminalization towards a public health approach. Proponents argue this will help reduce the burden on the criminal justice system and promote harm reduction strategies, while critics may express concerns about drug use normalization and potential public safety issues.

Summary

House Bill 07065 aims to decriminalize possession of small amounts of psilocybin, a psychoactive compound found in certain mushrooms, effective October 1, 2025. Under the new law, individuals found in possession of less than one-half ounce of psilocybin would be subject to fines instead of criminal charges, with a first offense resulting in a $150 fine and subsequent offenses levied between $200 and $500. This represents a significant shift in drug policy, focusing on reducing criminal penalties for personal use, particularly considering the increasing interest and research into the potential mental health benefits of psilocybin.

Sentiment

The overall sentiment surrounding the bill reflects a growing acceptance of psilocybin as an alternative therapeutic option for mental health treatment. Supporters, including various health advocates and some lawmakers, highlight the benefits that psilocybin can offer, particularly in treating conditions such as depression and PTSD. Meanwhile, opponents may argue against the potential risks associated with decriminalization, emphasizing the need for stricter regulations regarding psychoactive substances.

Contention

Notable points of contention regarding HB 07065 include debates on public health implications, law enforcement concerns, and the societal readiness for such a change in drug policy. There is also discussion about the adequacy of educational programs to inform the public about responsible use and potential risks of psilocybin. The bill’s passage marks a critical moment in the state’s approach to drug policy and mental health, reflecting broader national trends toward more lenient drug laws and exploration of alternative treatment options.

Companion Bills

No companion bills found.

Similar Bills

CA AB3171

Controlled substances: fentanyl.

CA AB1058

Controlled substances: fentanyl.

CA SB1070

Controlled substances: possession of firearms.

CA SB1489

Peace officers: Peace Officer Standards Accountability Advisory Board.

CA AB696

Controlled substances.

CA SB58

Controlled substances: decriminalization of certain hallucinogenic substances.

CA SB237

Controlled substances: fentanyl.

CA AB2467

Controlled substances: fentanyl.